Moderna Stock News
$69.86
2.96%
yesterday
Nasdaq,
Sep 18, 10:17 pm CET
Moderna Stock News
Negative
Barrons
●
4 days ago
Bridgewater Associates slashed a stake in Apple, halved its Lilly investment, doubled down on Microsoft, and bought Moderna in the second quarter.
Neutral
The Motley Fool
●
4 days ago
Analyzing the board of directors is a quick way to assess people power. Scientific advisory boards are easier to analyze than they might seem.
Positive
The Motley Fool
●
5 days ago
Moderna's shares climbed in the first half of the year, as it scored victories with a product approval and solid clinical trial results. This week the biotech surprised investors with some changes to its strategy -- and a key goal.
Negative
Investopedia
●
5 days ago
Shares of Moderna (MRNA) fell for the second day in a row after the company said it would slash its research and development expenditures.
Negative
Market Watch
●
5 days ago
Moderna's cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some products and questioned when the company can return to profitability.
Negative
Fast Company
●
5 days ago
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of low sales projections and poor vaccine sales.
Negative
Barrons
●
6 days ago
Analysts come up with their key catalyst watch list that can help Moderna shares get out of the rut.
Positive
The Motley Fool
●
6 days ago
Moderna may have a number of new product launches ahead. Pfizer is a big pharma stock that's poised for a big comeback.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
